ISOPLEXIS CORPORATION
Bruker Cellular Analysis | Home
BRANFORD, United States · Founded 2015 · $123.5M raised
- Headquarters
- BRANFORD, Connecticut
- Employees
- 51–200
- Founded
- 2015
- Website
- isoplexis.com
- Total Funding
- $123.5M
- Last Round
- $85.0M Series DJan 2021
About
IsoPlexis developed functional proteomics platforms enabling single-cell protein analysis to characterize immune cell function for drug development and cancer immunotherapy research. The company's IsoLight and IsoSpark systems used proprietary CodePlex technology to measure polyfunctional immune cell responses at the single-cell level. IsoPlexis was acquired by Berkeley Lights in March 2023, forming the combined company PhenomeX (Nasdaq: CELL).
Summary
ISOPLEXIS CORPORATION is a company based in BRANFORD, United States, founded in 2015. It has raised $123.5M in total, most recently a $85.0M Series D round in Jan 2021.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Funding History
No funding data available yet.
Know something? Help us improve our data.